change of name in investigational products [Regulatives / Guidelines]

posted by drgunasakaran1  – 2012-11-24 16:06 (4962 d 22:31 ago) – Posting: # 9582
Views: 3,732

Dear Mr Balavivekanand,

If there is change only in the Trade Name of the Reference product and manufacturer details, you can raise protocol amendment for the same. You need to get Ethics committee approval for your amendments and send an Intimation letter to the Regulatory body along with your Ethics Committee approved protocol amendment before initiating the study.

Kindly be informed that if there is a change in the dosage form, strength of the reference product, frequency of administration etc., we need to get approval from both the Ethics Committee and Regulatory body before conducting the study.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
375 visitors (0 registered, 375 guests [including 13 identified bots]).
Forum time: 15:38 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5